Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Blood-based biomarkers of Alzheimer's disease: diagnostic algorithms and new technologies

Carmona P, Molina M, Toledano A.

Curr Alzheimer Res. 2016;13(4):450-64. doi: 10.2174/1567205013666151116130301.

Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?

Merino JJ, Muñetón-Gómez V, Alvárez MI, Toledano-Díaz A.

Curr Alzheimer Res. 2016;13(4):403-12. doi: 10.2174/1567205013666151116125714.

Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis

Xu J, Xia LL, Song N, Chen SD, Wang G.

Curr Alzheimer Res. 2016;13(3):215-22. doi: 10.2174/1567205013666151218145752.

Alzheimer's disease: the amyloid hypothesis on trial

Harrison JR, Owen MJ.

Br J Psychiatry. 2016 Jan;208(1):1-3. doi: 10.1192/bjp.bp.115.167569.

Oxidative challenge in Alzheimer's disease: state of knowledge and future needs

Cervellati C, Wood PL, Romani A, Valacchi G, Squerzanti M, Sanz JM, Ortolani B, Zuliani G.

J Investig Med. 2016 Jan;64(1):21-32. doi: 10.1136/jim-2015-000017.

Biochemical and Radiological Markers of Alzheimer's Disease Progression

Dziedzic T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, Slowik A.

J Alzheimers Dis. 2016;50(3):623-44. doi: 10.3233/IFS-150578.

Suspected non-Alzheimer disease pathophysiology--concept and controversy

Jack CR Jr, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ.

Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18.

Rethinking on the concept of biomarkers in preclinical Alzheimer's disease

Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A.

Neurol Sci. 2016 May;37(5):663-72. doi: 10.1007/s10072-016-2477-1. Epub 2016 Jan 20.

Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis

Bao J, Wang XJ, Mao ZF.

Med Sci Monit. 2016 Jan 22;22:234-43. doi: 10.12659/msm.895622.

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease

Counts SE, He B, Prout JG, Michalski B, Farotti L, Fahnestock M, Mufson EJ.

Curr Alzheimer Res. 2016;13(7):800-8. doi: 10.2174/1567205013666160129095649.

Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment

González-Domínguez R, Rupérez FJ, García-Barrera T, Barbas C, Gómez-Ariza JL.

Curr Alzheimer Res. 2016;13(6):641-53. doi: 10.2174/1567205013666160129095138.

Amyloid imaging: Past, present and future perspectives

Villemagne VL.

Ageing Res Rev. 2016 Sep;30:95-106. doi: 10.1016/j.arr.2016.01.005. Epub 2016 Jan 28.

Neuroimaging biomarkers in Alzheimer's disease and other dementias

Villemagne VL, Chételat G.

Ageing Res Rev. 2016 Sep;30:4-16. doi: 10.1016/j.arr.2016.01.004. Epub 2016 Jan 28.

Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives

Wang J, Tan L, Yu JT.

J Alzheimers Dis. 2016;50(4):927-45. doi: 10.3233/JAD-150826.

Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review

Hung AS, Liang Y, Chow TC, Tang HC, Wu SL, Wai MS, Yew DT.

Prog Histochem Cytochem. 2016 May;51(1):1-8. doi: 10.1016/j.proghi.2016.01.001. Epub 2016 Jan 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias